Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer by Manish Kohli, Rui Qin, Rafael Jimenez, Scott M. Dehm

“…Recent therapeutic advances for managing advanced prostate cancer include the successful targeting of the androgen-AR axis with several new drugs in castrate resistant prostate cancer including abiraterone acetate and enzalutamide (MDV3100). …”
Get full text

Urodynamic Evaluation after High-Intensity Focused Ultrasound for Patients with Prostate Cancer by Luigi Mearini, Elisabetta Nunzi, Silvia Giovannozzi, Luca Lepri, Carolina Lolli, Antonella Giannantoni

“…Prostate Cancer…”
Get full text

Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix by Shawn Y. Ong, Josephine Taverna, Clint Jokerst, Thomas Enzler, Emad Hammode, Elisa Rogowitz, Myke R. Green, Hani M. Babiker

“…Disseminated intravascular coagulation (DIC) with excessive fibrinolysis (XFL) is a rare and acute life-threatening variant of DIC in patients with prostate cancer. Patients present with coagulopathy, hypofibrinogenemia, and systemic bleeding. …”
Get full text

Investigating the Role of Osteopontin (OPN) in the Progression of Breast, Prostate, Renal and Skin Cancers by Gautam Kundu, Selvakumar Elangovan

Subjects: Get full text

Ultrasound super-resolution imaging for non-invasive assessment of microvessel in prostate lesion by Xin Huang, Huarong Ye, Yugang Hu, Yumeng Lei, Yi Tian, Xingyue Huang, Jun Zhang, Yao Zhang, Bin Gui, Qianhui Liu, Ge Zhang, Qing Deng

Subjects: “…Prostate lesion…”
Get full text

Trends in incidence and mortality of prostate cancer in Ningbo City from 2011 to 2023 by ZHANG Qun，WANG Yong，CHEN Jieping，BAO Kaifang，FENG Yueyi，Wang Xiaoli

Subjects: “…prostate cancer…”
Get full text

Prognostic value of intraductal carcinoma subtypes and postoperative radiotherapy for localized prostate cancer by Fang Cao, Qing Li, Tianyu Xiong, Yingjie Zheng, Tian Zhang, Mulan Jin, Liming Song, Nianzeng Xing, Yinong Niu

Subjects: “…Prostate cancer…”
Get full text

Cancer Detection Rates of Systematic and Targeted Prostate Biopsies after Biparametric MRI by Maudy C. W. Gayet, Anouk A. M. A. van der Aa, Harrie P. Beerlage, Bart Ph Schrier, Maaike Gielens, Roel Heesakkers, Gerrit J. Jager, Peter F. A. Mulders, Hessel Wijkstra

“…Prostate Cancer…”
Get full text

15 Proteome signatures in urinary extracellular vesicles enable prostate cancer detection by I.V. Bijnsdorp, L.A. Erozenci, J.C. Knol, T.V. Pham, S.R. Piersma, G. Verhaegh, J.A. Schalken, G. Jenster, E. van Royen M.E.,Martens-Uzunova, R.J.A. Van Moorselaar, C.R. Jimenez

Get full text

Unusual Cushing’s Syndrome and Hypercalcitoninaemia due to a Small Cell Prostate Carcinoma by Antonio Balestrieri, Elena Magnani, Fiorella Nuzzo

“…Total body computed tomography (TBCT) and 68 Gallium DOTATATE PET/CT localized a voluminous prostate tumour. A subsequent transurethral prostate biopsy documented a small cell carcinoma positive for ACTH and calcitonin and negative for prostatic specific antigen (PSA) at immunocytochemical study; serum prostatic specific antigen (PSA) was normal. …”
Get full text

Heterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: Implications for prognosis and immunotherapy by Chen Ding, Jiange Wang, Jie Wang, Jiqiang Niu, Zhikai Xiahou, Zhou Sun, Zhenzhen Zhao, Dongyang Zeng

Subjects: Get full text

Specimen Orientation by Marking the Peripheral End: (Potential) Clinical Advantages in Prostate Biopsy by Andrea Benedetto Galosi, Giovanni Muzzonigro, Vito Lacetera, Roberta Mazzucchelli

“…Prostate Cancer…”
Get full text

The Biopsychosocial Burden of Prostate Biopsy at the Time of Its Indication, Procedure, and Pathological Report by Walker W. Laranja, Brunno C. F. Sanches, Brunno R. I. Voris, João C. C. Alonso, Fabiano A. Simões, Ronald F. Rejowski, Leonardo O. Reis

“…Prostate Cancer…”
Get full text

Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer by Maria E. Pretorius, Håkon Wæhre, Vera M. Abeler, Ben Davidson, Ljiljana Vlatkovic, Ragnhild A. Lothe, Karl-Erik Giercksky, Håvard E. Danielsen

“…Background: The clinical outcome for the individual prostate cancer patient is often difficult to predict, due to lack of reliable independent prognostic biomarkers. …”
Get full text

Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions by Marina G. Gobbo, Nishtman Dizeyi, Per-Anders Abrahamsson, Per-Anders Bertilsson, Viviane Sanches Masitéli, Eloisa Zanin Pytlowanciv, Sebastião R. Taboga, Rejane M. Góes

“…The antitumor properties of melatonin (MLT) are known for prostate cancer cells. This study investigated whether MLT affects prostate maturation and interferes with tissue injuries induced by diabetes. …”
Get full text

Interactions between key genes and pathways in prostate cancer progression and therapy resistance by Fan Wu, Hengsen Zhang, Miaomiao Hao

Subjects: Get full text

Gut microbiota, metabolites, and cytokines in relation to the risk of prostate cancer in the Asian population by Zhengshi Wang, Zhengshi Wang, Zhengshi Wang, Zhengshi Wang, Zhengshi Wang, Haotian Chen, Haotian Chen, Yongqiang Liu, Yongqiang Liu, Libin Zou, Libin Zou, Zhijin Zhang, Zhijin Zhang, Zhiqiang Yin, Zhiqiang Yin, Shiyu Mao, Shiyu Mao, Changcheng Guo, Changcheng Guo, Bin Yang, Bin Yang, Pengfei Wu, Pengfei Wu, Pengfei Wu, Xudong Yao, Xudong Yao

Subjects: “…prostate cancer…”
Get full text

Metabolomic profile and its association with the diagnosis of prostate cancer: a systematic review by Angela Patricia Salinas Pita, Mildrey Mosquera Escudero, Eliecer Jiménez-Charris, Herney Andrés García-Perdomo

Subjects: Get full text

Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate by Lu Yu Kuo, Zhong Li Titus Lim, Caitlin Letch, Joshua Silverman, Jason Jae Yeun Kim, Scott McClintock

“…Abstract Objectives To evaluate the utility of the HAS‐BLED bleeding risk‐estimation tool to predict for clinically significant postoperative haematuria in patients receiving transurethral resection of prostate (TURP). Patients and Methods A single‐centre, retrospective cohort analysis of patients underwent TURP from April 2019 to December 2023 for treatment of symptomatic benign prostate hyperplasia. …”
Get full text

Urolithin A increases the natural killer activity of PBMCs in patients with prostate cancer by Vladimir Rogovskii, Vladimir Rogovskii, Vladimir V. Murugin, Vladimir V. Murugin, Nikolay Vorobyev, Nikolay Vorobyev, Sergey Popov, Nikolay Sturov, Alexey Krasheninnikov, Alexander Morozov, Marina Prokhorova

Subjects: Get full text